INTRODUCTION
============

Uncoupling proteins (UCPs) are a small family of mitochondrial carrier proteins with five identified members in mammalian systems. The first discovered UCP1 was localized in brown adipose tissue and was shown to dissipate the proton gradient, which generated heat through uncoupling of oxidative phosphorylation from the electron transport chain ([@b40-molce-39-9-680]). Several studies suggest that UCPs might be involved in many metabolic functions, including fatty acid transport, regulation of insulin secretion, and regulation of mitochondrial superoxide generation ([@b14-molce-39-9-680]). UCP2 was suggested to be a negative regulator of insulin secretion and acted through a mild uncoupling mechanism ([@b7-molce-39-9-680]). Moreover, UCP2 and UCP3 are activated by superoxide from the mitochondrial inner membrane ([@b16-molce-39-9-680]; [@b46-molce-39-9-680]). It was proposed that UCPs could reduce mitochondrial reactive oxygen species (ROS) generation, and therefore attenuate damage derived from these molecules ([@b39-molce-39-9-680]). In a recent study, endothelial UCP2 was shown to function mainly in the control ROS generation in mitochondria during hyperglycemia ([@b33-molce-39-9-680]). Moreover, the recently identified UCP4 and UCP5 were specifically localized in the brain, and their roles were suggested to be in the modulation of energy production and mitochondrial ROS levels ([@b36-molce-39-9-680]; [@b43-molce-39-9-680]; [@b52-molce-39-9-680]). Ectopic expression of these proteins resulted in lower mitochondrial membrane potential (ψ~m~) and ROS content. It was proposed that high ψ~m~ is strongly correlated with increases in ROS in mitochondria, and consequently mitochondrial oxidative damage ([@b5-molce-39-9-680]; [@b14-molce-39-9-680]; [@b18-molce-39-9-680]). It was indeed demonstrated that 4-hydroxynonenal (HNE), derived from lipid peroxidation, reduced mitochondrial ROS production, through uncoupling, and decreased ψ~m~ ([@b14-molce-39-9-680]; [@b17-molce-39-9-680]).

Under restricted diet conditions, UCP2, 4, and 5 levels were shown to increase, which was associated with decreased ROS production and reduced neurodegeneration in models of Parkinson's disease ([@b13-molce-39-9-680]; [@b14-molce-39-9-680]; [@b45-molce-39-9-680]). It has been suggested that UCPs regulate pathways involved in neurodegeneration, and protect against neurodegenerative diseases and aging through controlling ROS-induced oxidative stress. In addition, it was reported that *Ucp2* knockout mice have enhanced resistance to the parasite *Toxoplasma*, presumably through increased ROS production in macrophages ([@b1-molce-39-9-680]).

Surprisingly there are few studies on UCP in *Caenorhabditis elegans* (*C. elegans*), despite this species providing a good research model. *C. elegans* has only one UCP, UCP-4, which is a homologue of mammalian UCP4 ([@b29-molce-39-9-680]). According to a study by [@b29-molce-39-9-680], despite elevated ATP levels, there were no significant differences between wild type and *ucp-4* mutants in terms of life span, temperature tolerance, and resistance to applied oxidative stress. However, the *ucp-4* mutant was sensitive to cold stress. This indicates that *ucp-4* in *C. elegans* has a role as a thermogenin. In addition, it was suggested that ceUCP4 controls succinate transport to achieve regulation of complex II-mediated oxidative phosphorylation ([@b42-molce-39-9-680]). Given that mammals have multiple UCPs with multiple functions, the single *C. elegans* UCP could be multifunctional and involved in several mechanisms. However, its role in neuronal aging and innate immunity is not known. We therefore investigated the role of *C. elegans* UCP4 in neuronal aging and pathogen resistance.

MATERIALS AND METHODS
=====================

Strains and constructs
----------------------

Wild type Bristol N2 strain, *ucp-4* deletion mutant (*ok195*), and CZ10175 *zdIs5* (*Pmec-4::gfp*) were obtained from the *Caenorhabditis* Genetics Center (CGC) at the University of Minnesota. The *ucp-4* deletion mutant was crossed to *zdIs5* to obtain *ucp-4 (ok195);zdIs5* (*Pmec-4::gfp*). We cultured *C. elegans* according to published protocols ([@b6-molce-39-9-680]).

To clone the *ucp-4* promoter region, approximately 1.9 kb of the 5′-upstream region of *ucp-4* gene was amplified by polymerase chain reaction (PCR) using genomic DNA from worm lysate as a template. The amplified DNA was inserted into the Fire vector, pPD95.79 to generate *Pucp-4::gfp*. The amplified 1.6 kb *ucp-4* genomic DNA was combined with *Pucp-4::gfp* to construct *Pucp-4::ucp-4::gfp*. To obtain *ucp-4* overexpression constructs, the amplified 1.6 kb *ucp-4* fragment was cloned into the Fire vector, pPD49.83, *Phs::ucp-4*. Subsequently, the heat-shock promoter of the vector was replaced by the 1.9 kb *ucp-4* promoter region to generate *Pucp-4::ucp-4*. Microinjection was performed as previously described ([@b38-molce-39-9-680]) and the plasmid pRF4 containing a dominant gene (*rol-6*) was co-injected.

For RNAi bacterial feeding constructs, *ucp-4* cDNA was obtained by reverse transcription polymerase chain reaction (RT-PCR) followed by PCR. The amplified 1 kb *ucp-4* cDNA was inserted into the Fire feeding vector (L4440). The RNAi construct was introduced to HT115 (DE3) bacteria. Feeding experiments were performed as described by [@b31-molce-39-9-680].

MitoTracker and TMRE experiments
--------------------------------

MitoTracker Red CMXRos (Invitrogen, Life Technologies Corporation, USA) was prepared following the manufacturer's protocol and added to the growth media plate at a final concentration of 2 μg/ml. The worms were transferred to the media and incubation proceeded for 16 h.

Tetramethylrhodamine (TMRE, Invitrogen) is a cell-permeable and cationic fluorescent dye that is an indicator of mitochondrial membrane potential (ψ~m~) ([@b20-molce-39-9-680]; [@b35-molce-39-9-680]; [@b51-molce-39-9-680]). TMRE in DMSO (50 μM) was applied to the worm plates at a final concentration of 0.1 μM. Worms were incubated on TMRE plates for 16 h and then prepared for observation after washing with M9 buffer ([@b51-molce-39-9-680]). For ectopic overexpression experiments, heat shock was performed for 2 h at 30°C, 12 h before observation.

Observation of neuronal defects
-------------------------------

We scored an individual adult worm as one neuronal defect when it displayed at least one defect such as an outgrowth in the anterior lateral microtubule cells (ALM) or branching, blebbing, and waving in the posterior lateral microtubule cells (PLM) ([@b10-molce-39-9-680]). All observations were conducted using a fluorescent microscope (80i-DS-Fi1, Nikon). For assessing neuronal defects, animals with ectopic overexpression of target proteins were subjected to a mild heat shock at 25°C for 2 h every 24 h.

Pathogen experiments
--------------------

*Staphylococcus aureus* was cultured overnight at 37°C in BHI media, after which the culture was diluted 1:10 with the same media. This diluted solution (100 μl) was spread onto plates and incubated at 37°C for 6 h, followed by 6 h of cooling at 20°C. For treatment with heat-killed pathogens, plates were incubated at 65°C for 6 h to kill the pathogen. Worms were transferred to prepared media (previously seeded with heat-killed or live pathogens) and the live worms were counted every 6 h until no living worms remained. Data are presented as mean survival days, which were calculated using the OASIS program ([@b50-molce-39-9-680]).

RESULTS AND DISCUSSION
======================

*ucp-4* is expressed ubiquitously and UCP-4 is localized in the mitochondria in *C. elegans*
--------------------------------------------------------------------------------------------

A previous study reported that *ucp-4* was expressed in the head muscles, pharynx, and body wall muscles of *C. elegans* ([@b29-molce-39-9-680]). We investigated *ucp-4* expression and UCP-4 localization. Using a transcriptional reporter (*Pucp-4::gfp*), GFP expression indicated that *ucp-4* was expressed throughout the body of adult worms and that expression was initiated at an early developmental stage ([Figs. 1A and 1B](#f1-molce-39-9-680){ref-type="fig"}, respectively). *ucp-4* expression was observed in several tissues, including pharyngeal muscle, body wall muscle, and head sensory neurons ([Figs. 1C, 1D, and 1E](#f1-molce-39-9-680){ref-type="fig"} respectively). These results suggest that *ucp-4* was expressed in most tissues throughout the life of the worm. Regarding UCP-4 localization, a translational reporter (*Pucp-4::ucp-4::gfp*) was used. In UCP-4::GFP transgenic animals, GFP-tagged UCP-4 was specifically localized in the mitochondria of the body wall muscle and hypodermis ([Figs. 1F and 1G](#f1-molce-39-9-680){ref-type="fig"}). MitoTracker staining, overlaid with green fluorescence in the hypodermis, suggested that UCP-4 might be located inside the mitochondria, and probably in the inner membrane ([Fig. 1H](#f1-molce-39-9-680){ref-type="fig"}).

*ucp-4* mutant reveals increased mitochondrial membrane potential (ψ~m~)
------------------------------------------------------------------------

It has been suggested that increased mitochondrial membrane potential (ψ~m~) is positively associated with reactive oxygen species (ROS) generation in the mitochondria ([@b23-molce-39-9-680]; [@b32-molce-39-9-680]; [@b49-molce-39-9-680]). Moreover, UCPs dissipate the mitochondrial proton gradient, resulting in decreased ψ~m~ ([@b32-molce-39-9-680]). To determine if UCP-4 is involved in regulating ψ~m~, we used TMRE staining to visualize ψ~m~ in wild type, *ucp-4* mutant, and *ucp-4* overexpressing animals. As shown in [Fig. 2](#f2-molce-39-9-680){ref-type="fig"}, ψ~m~ was increased in the *ucp-4* mutants compared to that of wild type worms ([Figs. 2A and 2B](#f2-molce-39-9-680){ref-type="fig"}, respectively); this result was consistent with previous studies ([@b29-molce-39-9-680]; [@b30-molce-39-9-680]). To confirm the involvement of *ucp-4* in ψ~m~, *ucp-4* was overexpressed using a heat shock promoter, *Phs::ucp-4*, and the worms were stained by TMRE. TMRE intensity in overexpressing animals was lowest among all strains ([Fig. 2D](#f2-molce-39-9-680){ref-type="fig"}). Wild type animals with the heat shock promoter showed no difference in TMRE intensity compared to wild type animals; therefore, the heat shock promoter itself did not affect ψ~m~ ([Fig. 2C](#f2-molce-39-9-680){ref-type="fig"}). Low ψ~m~ in *ucp-4* overexpressing worms could be the result of proton gradient dissipation. Therefore, UCP-4 could lead to low energy efficiency and low ROS levels.

*ucp-4* mutant displays increased neuronal defects
--------------------------------------------------

Increased ROS, probably in the context of oxidative damage, is correlated with neuronal diseases such as Parkinson's and Alzheimer's ([@b19-molce-39-9-680]; [@b34-molce-39-9-680]). Human UCP2 was shown to protect neurons against oxidative stress ([@b37-molce-39-9-680]). We therefore examined if UCP-4 is involved in neuronal defects during the aging process. In recent reports, mechanosensory touch receptor neurons, anterior lateral microtubule cells (ALM) and posterior lateral microtubule cells (PLM), showed neuronal degenerations during aging, which included soma outgrowth, axon blebbing, and wavy processes ([@b41-molce-39-9-680]; [@b47-molce-39-9-680]; [@b48-molce-39-9-680]). In addition, ALM and PLM cells are well-studied and easily observed ([@b9-molce-39-9-680]). Therefore, We used the *zdIs5* (*Pmec-4::gfp*) background to observe and score ALMs and PLMs during aging. Imaging of touch receptor neurons in *zdIs5* worms showed ALM and PLM cells on day 1 ([Fig. 3A](#f3-molce-39-9-680){ref-type="fig"}). [Fig. 3B](#f3-molce-39-9-680){ref-type="fig"} shows standard ALM outgrowth and PLM wavy defects in the 10-day control animal. On day 15, severe ALM outgrowth and PLM waving and blebbing phenotypes were observed as aging progressed in control worms ([Figs. 3C, 3D, and 3E](#f3-molce-39-9-680){ref-type="fig"}).

To understand *ucp-4* function in neuronal aging, *ucp-4* deficient and *ucp-4* overexpressing worms were examined. First, both *ucp-4* deletion mutants and *ucp-4* RNAi treated animals were used for neuronal observation during aging to determine whether effects are the result of *ucp-4* itself. For RNAi treatment in worms, *ucp-4* RNAi was applied to *zdIs5* animals ([Figs. 3F and 3G](#f3-molce-39-9-680){ref-type="fig"}). [Figures 3F and 3G](#f3-molce-39-9-680){ref-type="fig"} show that ALM and PLM defects progressed in an age-dependent manner regardless of the presence of *ucp-4* (comparing day 1 to day 15). For example, ALMs in the 15-day control showed a 67% defect, which was much greater than the 14% defect in 1-day animals ([Fig. 3F](#f3-molce-39-9-680){ref-type="fig"}). Moreover, the *ucp-4* mutant showed markedly increased ALM defects, specifically, 22% on day 1 and 89% on day 15 ([Fig. 3F](#f3-molce-39-9-680){ref-type="fig"}). Animals treated with *ucp-4* RNAi showed similar results to those of the *ucp-4* mutant.

For PLMs, neuronal defects gradually increased with aging in control and *ucp-4* deficient animals ([Fig. 3G](#f3-molce-39-9-680){ref-type="fig"}). However, PLM waving phenotypes were much more severe in *ucp-4* mutants compared to that of control worms ([Fig. 3G](#f3-molce-39-9-680){ref-type="fig"}). Quantification indicated that both *ucp-4* mutants and *ucp-4* RNAi treated worms resulted in more neuronal defects compared to that in controls at all time points tested ([Figs. 3F and 3G](#f3-molce-39-9-680){ref-type="fig"}). These results suggest that only *ucp-4* contributes to neuronal defects during aging. For confirmation, *ucp-4* overexpressing animals were also studied during aging. *Pucp-4::ucp-4* and *Phs::ucp-4* constructs were injected into *zdIs5* for observation in overexpressing worms ([Figs. 3H and 3I](#f3-molce-39-9-680){ref-type="fig"}). On day 1, ALM and PLM phenotypes were not significantly different between controls (*Phs::gfp*) and *ucp-4* overexpressing animals (*Pucp-4::ucp-4* and *Phs::ucp-4*). As aging progressed, all animals showed a gradual increase in neuronal defects ([Figs. 3H and 3I](#f3-molce-39-9-680){ref-type="fig"}). However, both *ucp-4* overexpressing animals (*Pucp-4::ucp-4* and *Phs::ucp-4*) consistently presented a lower number of defects compared to that in either group of control animals (*Pucp-4::gfp* and *Phs::gfp*) ([Figs. 3H and 3I](#f3-molce-39-9-680){ref-type="fig"}). These results led us to conclude that UCP-4 attenuates neuronal defects during aging, probably by lowering the mitochondrial membrane potential (ψ~m~) and consequently lowering ROS levels.

According to the free radical theory, ROS might cause aging and aging-related disease ([@b25-molce-39-9-680]). Mild uncoupling by UCPs resulting in lowered ROS levels can alleviate aging and aging-associated diseases such as Parkinson's and Alzheimer's disease that are driven by oxidative damage. However, this has not yet been clearly proven ([@b4-molce-39-9-680]; [@b12-molce-39-9-680]). The quantification of a mild uncoupling effect requires the development of specific methods to measure physiological ROS content, especially in native conditions ([@b12-molce-39-9-680]). Despite technical difficulty, the application of mild uncoupling has shown beneficial results. For example, mice expressing muscle-specific UCP1 showed decreased adiposity, increased metabolic rate, and diminished age-related diseases ([@b21-molce-39-9-680]). *Ucp2* overexpressing mice showed neuronal protection after global ischemia and after transient focal ischemia ([@b11-molce-39-9-680]; [@b22-molce-39-9-680]) Moreover, our results suggest that *ucp-4* overexpression in *C. elegans* alleviates neuronal defects that occur during aging. Therefore, UCPs can regulate ψ~m~, which protects neurons during aging. Proper application of mild uncoupling might be useful to treat metabolic or age-related diseases. Further studies are required to establish mild uncoupling and determine how it is regulated during age-related neurodegeneration.

The *ucp-4* mutant is resistant to the pathogen *S. aureus*
-----------------------------------------------------------

Increased ROS can cause oxidative damage, especially in the mitochondria ([@b24-molce-39-9-680]). However, an increase in ROS can be beneficial for innate immunity as a major defense system against pathogens ([@b1-molce-39-9-680]; [@b3-molce-39-9-680]). Moreover, in *C. elegans*, increased ROS levels were shown to occur in the intestine at the site of pathogen infection ([@b8-molce-39-9-680]). Because UCP-4 is involved in regulating mitochondrial membrane potential (ψ~m~), we investigated the function of UCP-4 in the response to pathogens. First, we compared ψ~m~ using TMRE staining in wild types and in *ucp-4* mu tants upon exposure to either live (pathogenic) or heat-killed (non-pathogenic) *Staphylococcus aureus* (*S. aureus*). As seen in [Fig. 4](#f4-molce-39-9-680){ref-type="fig"}, the *ucp-4* mutant had high ψ~m~ compared to that of the wild type without pathogen exposure ([Figs. 4A and 4C](#f4-molce-39-9-680){ref-type="fig"}, respectively). After pathogen exposure, there was no significant change in ψ~m~ between live and heat-killed pathogen exposed *ucp-4* mutants ([Fig. 4D](#f4-molce-39-9-680){ref-type="fig"}). In contrast, wild type worms showed an increase in ψ~m~ upon exposure to live pathogens ([Fig. 4B](#f4-molce-39-9-680){ref-type="fig"}).

This increased ψ~m~ could be related to pathogen resistance; we therefore assayed worm survival. We placed animals on pathogen-seeded plates during each developmental stage, specifically egg, L1--2, L3--4, and adult day 1, 5, and 10. After the worms were transferred, surviving animals were counted each day until all were dead. We used the OASIS program to calculate mean survival days based on the raw data ([@b50-molce-39-9-680]). As seen in [Fig. 4E](#f4-molce-39-9-680){ref-type="fig"}, the *ucp-4* mutant survived longer than the wild type when exposed to the pathogen at the egg stage, L1--2, L3--4, and the young adult stage (day 1). However, exposure at the aged adult stages (days 5 and 10) produced different results. Specifically, the *ucp-4* mutants were more susceptible to the pathogen compared to wild type at this stage.

Considering the increase in ψ~m~ in wild type animals upon pathogen exposure, the resulting increase in ROS could serve to initiate an immune response. However, the *ucp-4* mutant displayed high ROS levels without the presence of the pathogen, which could account for the observed resistance. As shown in [Fig. 4](#f4-molce-39-9-680){ref-type="fig"}, *ucp-4* mutants exposed to pathogens at an early stage showed increased resistance, but were susceptible when exposed to the pathogen in an aged adult stage. This inconsistency between young and aged animals might be due to the free radical aging process and/or gradual ROS response ([@b27-molce-39-9-680]). It was shown that silencing UCP2 in macrophages resulted in increased ROS production that could kill the pathogen via direct oxidative damage. As a result, the UCP2 knocked-down macrophage showed enhanced resistance to the *Leishmania* parasite ([@b3-molce-39-9-680]). When young *ucp-4* mutants were exposed to the pathogen, the increased ROS could function as microbicidal molecules. In addition, increased ROS could facilitate an immune response-during pathogen attack. Indeed, a recent study showed that moderately increased ROS in the mitochondria enhances immunity against pathogens via a feedback mechanism involving hypoxia-inducible factor 1 (HIF-1) and AMP-activated protein kinase (AMPK) in *C. elegans* ([@b28-molce-39-9-680]).

Alternatively, high levels of ROS can cause oxidative damage. It was observed that various organisms accumulated oxidative damage of macromolecules such as DNA, proteins, and lipids during aging ([@b2-molce-39-9-680]; [@b24-molce-39-9-680]; [@b25-molce-39-9-680]; [@b26-molce-39-9-680]; [@b44-molce-39-9-680]). When *ucp-4* mutants aged, their macromolecules could be progressively damaged by increased ROS. The cumulative damage via ROS and aging in the *ucp-4* mutant could cause susceptibility to the pathogen. ROS increases can thus function in two opposite ways. The initial ROS increase against a pathogen attack could be beneficial to kill the pathogen and trigger an immune response. However, the constant high level of ROS could cause deterioration of structures consisting of physical barriers to infection by pathogen. Since ROS can exert both positive and negative responses, the regulation of ROS levels could be critical for innate immunity. This dual role is probably tightly linked to ROS balance; therefore, further studies are necessary to elucidate how the ROS balance in the innate immune system is sensed and regulated during pathogen exposure.
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![*ucp-4* expression and UCP-4 localization in *C. elegans*. *ucp-4* was expressed throughout the entire body (A) and in a comma stage embryo (B) in the transgenic animal carrying *Pucp-4::gfp*. Higher magnification showed intense expression of *ucp-4* in pharyngeal muscle and head neurons (C, arrows and arrowheads, respectively), body wall muscle (D), and head neurons (E, arrows). UCP-4 was localized in the body wall muscles and in the hypodermis (F and G respectively) in the transgenic worm carrying the *Pucp-4::ucp-4::gfp* construct. (H) The same hypodermis image in G stained with MitoTracker is presented. Scale bars = 50 μm.](molce-39-9-680f1){#f1-molce-39-9-680}

![The *ucp-4* mutant shows increased mitochondrial membrane potential (ψ~m~). ψ~m~ was assessed by TMRE. WT, wild type (A); *ucp-4*, *ucp-4* mutant (B); *Phs::gfp* (C); *Phs::ucp-4*, *ucp-4* overexpression under control of the heat shock promoter (D). Scale bar = 100 μm.](molce-39-9-680f2){#f2-molce-39-9-680}

![Neuronal defects are increased in the *ucp-4* mutant. (A--E) A representative image of a mechanosensory neuron from a control worm is presented on day 1 (A), 10 (B), and 15 (C, D, and E). An arrow indicates ALM outgrowth and arrowheads indicate PLM waving in B. Arrows show ALM outgrowth in C; arrows indicate PLM branching in D. Arrows indicate PLM blebbing and arrowheads show PLM waving in E. Scale bars = 50 μm. (F and H) ALM neuronal defects in the *ucp-4* mutant and in *ucp-4* RNAi treated worms (F) and *ucp-4* overexpressing animals (H) are presented as a percentage relative to that of control animals. (G and I) PLM neuronal defects in the *ucp-4* mutant and in *ucp-4* RNAi treated worms (G) and ucp-4 overexpressing animals (I) are presented as a percentage relative to that of the control. *zdIs5*, *zdIs5* (*Pmec-4::gfp*); *zdIs5;ucp-4* (*ok195*), *ucp-4* in *zdIs5*; *zdIs5* + vector (L4440), empty vector (L4440) in *zdIs5*; *zdIs5* + *ucp-4* RNAi, *zdIs5* treated with *ucp-4* RNAi (F and G). *zdIs5* + *Pucp-4::gfp*, *Pucp-4::gfp* in *zdIs5*; *zdIs5* + *Pucp-4::ucp-4*, *Pucp-4::ucp-4* in *zdIs5*; *zdIs5* + *Phs::gfp*, *Phs::gfp* in *zdIs5*; *zdIs5* + *Phs::ucp-4*, *Phs::ucp-4* in *zdIs5* (H and I) n \> 100 worms per line in each experiment. Four independent experiments were performed. Error bars represent SD. ^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01, based on a Student's *t*-test.](molce-39-9-680f3){#f3-molce-39-9-680}

![Deficiency of UCP-4 results in resistance to *S. aureus*. Mitochondrial membrane potential (ψ~m~) was measured by TMRE after wild type worms were fed heat-killed or live *S. aureus* (A and B, respectively). (C) and (D) represent TMRE stained *ucp-4* mutants feeding on either heat-killed or live *S. aureus*, respectively. Scale bar = 100 μm. (E) Mean survival days of the wild type and the *ucp-4* mutant after exposure to pathogen-seeded plates. Each experimental result was calculated by OASIS. The average of five experimental replicates was plotted. n \> 300 worms per line in each experiment. WT, wild type; *ucp-4*, *ucp-4* mutant; egg, animals were exposed to the pathogen at the egg stage; L1--2, at L1--2 stage; L3--4, at L3--4 stage; adult day 1, 5, and 10, at day 1, 5, and 10, respectively. Error bars = SD. ^\*^*p* \< 0.05; ^\*\*^*p* \< 0.01, based on a Student's *t*-test.](molce-39-9-680f4){#f4-molce-39-9-680}
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